key: cord-1045439-shmitjd7
authors: John, Thadathilankal-Jess; John, Kiran
title: What is the Role of Angiotensin Converting Enzyme 2 (ACE2) in COVID-19 Infection in Hypertensive, Diabetic Patients?
date: 2020-04-08
journal: Can J Cardiol
DOI: 10.1016/j.cjca.2020.03.049
sha: 6626d7a2a0c8cbde33d8569a0c2325b5d3475df0
doc_id: 1045439
cord_uid: shmitjd7

nan

This however does not take away from the recognizing this subtle balance between the ACE/ACE2 pathways and how it may contribute to the development of lung injury in SARS-CoV-2. It is thus suggested that modulators of the RAAS system may be therapeutic targets against SARS-CoV-2. The findings of current trials using ARBs as well as early phase 2B trials using intravenous recombinant human ACE2 may provide further evidence to support the suggestions of Bombardini et.al. (4) 

Angiotensin converting enzyme 2 as the molecular bridge between epidemiologic and clinical features of COVID-19

Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease

ACE2: A new target for prevention of diabetic nephropathy

SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?